Free Trial

20 Stocks Wall Street Analysts Love the Most

Every trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equities research analysts. There are between 300 and 500 brokerages and research houses that issue ratings, price targets and recommendations and more than 5,000 securities around the world that regularly receive coverage from research analysts.

MarketBeat has tracked more than 170,000 distinct analyst recommendations in the last 12 months alone. Given the volume of ratings changes that occur each day, it can be difficult to sift through the noise.

Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when more than a dozen different analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same stock.

This slide show lists the 20 companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

#1 - Ryanair (NASDAQ:RYAAY)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
5 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$151.00 (244.6% Upside)

About Ryanair

Ryanair logoRyanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, and internationally. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/11/2024UBS GroupUpgradeHold ➝ Strong-Buy
10/25/2024BarclaysUpgradeEqual Weight ➝ Overweight
8/29/2024Sanford C. BernsteinLower Price TargetOutperform ➝ Outperform$149.00 ➝ $147.00
8/9/2024The Goldman Sachs GroupUpgradeStrong-Buy
8/2/2024CitigroupUpgradeStrong-Buy
7/12/2024Hsbc Global ResUpgradeHold
7/12/2024HSBCDowngradeBuy ➝ Hold
6/21/2024BarclaysDowngradeOverweight ➝ Equal Weight
6/20/2024UBS GroupDowngradeBuy ➝ Neutral
5/24/2024Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold

#2 - Amdocs (NASDAQ:DOX)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$101.20 (18.1% Upside)

About Amdocs

Amdocs logoAmdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/14/2024BarclaysLower Price TargetOverweight ➝ Overweight$113.00 ➝ $111.00
11/13/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$98.00 ➝ $105.00
10/2/2024Stifel NicolausInitiated CoverageBuy$100.00
5/9/2024CitigroupLower Price TargetBuy ➝ Buy$105.00 ➝ $100.00
5/9/2024Robert W. BairdLower Price TargetNeutral ➝ Neutral$97.00 ➝ $90.00
2/8/2024BarclaysBoost Price TargetOverweight ➝ Overweight$105.00 ➝ $115.00
1/17/2024CitigroupBoost Price TargetBuy ➝ Buy$96.00 ➝ $104.00
12/1/2023Jefferies Financial GroupInitiated CoverageBuy$105.00
8/3/2023OppenheimerBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $109.00
6/16/2023Bank of AmericaBoost Price Target$100.00 ➝ $110.00

#3 - Fresenius Medical Care (NYSE:FMS)

Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$25.30 (9.7% Upside)

About Fresenius Medical Care

Fresenius Medical Care logoFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/6/2025Truist FinancialBoost Price TargetHold ➝ Hold$23.00 ➝ $25.00
12/2/2024Bank of AmericaUpgradeUnderperform ➝ Neutral
11/6/2024Berenberg BankInitiated CoverageBuy$25.60
10/7/2024Truist FinancialBoost Price TargetHold ➝ Hold$22.00 ➝ $23.00
7/31/2024Truist FinancialLower Price TargetHold ➝ Hold$24.00 ➝ $22.00
5/15/2024Truist FinancialBoost Price TargetHold ➝ Hold$21.00 ➝ $24.00
1/8/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight
11/24/2023HSBCUpgradeReduce ➝ Hold
11/17/2023Societe GeneraleUpgradeHold ➝ Buy
10/11/2023Truist FinancialLower Price TargetHold ➝ Hold$28.00 ➝ $24.00

#4 - Cameco (NYSE:CCJ)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$66.56 (24.2% Upside)

About Cameco

Cameco logoCameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/4/2024Janney Montgomery ScottUpgradeStrong-Buy
9/3/2024National Bank FinancialUpgradeStrong-Buy
8/19/2024ScotiabankLower Price TargetOutperform ➝ Outperform$81.00 ➝ $80.00
8/14/2024Glj ResearchReiterated RatingBuy ➝ Buy$63.73 ➝ $63.73
7/31/2024Cantor FitzgeraldUpgradeNeutral ➝ Overweight
6/26/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$59.00 ➝ $60.50
6/7/2024The Goldman Sachs GroupBoost Price TargetBuy ➝ Buy$56.00 ➝ $62.00
4/1/2024The Goldman Sachs GroupInitiated CoverageBuy$55.00
12/19/2023Cantor FitzgeraldDowngradeBuy ➝ Neutral
10/25/2023Cantor FitzgeraldUpgradeHold ➝ Buy

#5 - JD.com (NASDAQ:JD)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
11 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$41.36 (7.4% Upside)

About JD.com

JD.com logoJD.com, Inc operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/9/2024Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$43.00 ➝ $46.00
11/15/2024CitigroupLower Price TargetBuy ➝ Buy$52.00 ➝ $51.00
11/15/2024BenchmarkReiterated RatingBuy ➝ Buy$47.00 ➝ $47.00
10/21/2024Loop CapitalUpgradeHold ➝ Buy$49.00 ➝ $48.00
10/16/2024BarclaysBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $50.00
10/16/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$40.00 ➝ $50.00
10/15/2024BenchmarkReiterated RatingBuy ➝ Buy$47.00 ➝ $47.00
8/19/2024SusquehannaReiterated RatingNeutral ➝ Neutral$28.00 ➝ $28.00
8/16/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$33.00 ➝ $36.00
8/16/2024Sanford C. BernsteinLower Price TargetMarket Perform ➝ Market Perform$35.00 ➝ $32.00

#6 - BHP Group (NYSE:BHP)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
3 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$53.00 (5.6% Upside)

About BHP Group

BHP Group logoBHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, the rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/6/2025Jefferies Financial GroupLower Price TargetHold ➝ Hold$57.00 ➝ $53.00
10/4/2024Jefferies Financial GroupDowngradeBuy ➝ Hold$72.00 ➝ $68.00
9/19/2024ArgusUpgradeStrong-Buy
9/16/2024Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform
5/31/2024CitigroupInitiated CoverageBuy ➝ Buy
5/30/2024BarclaysReiterated RatingEqual Weight
3/14/2024CitigroupUpgradeNeutral ➝ Buy
3/5/2024Liberum CapitalReiterated RatingBuy ➝ Hold
10/5/2023UBS GroupUpgradeSell ➝ Neutral
9/25/2023Sanford C. BernsteinDowngradeOutperform ➝ Market Perform

#7 - Novo Nordisk A/S (NYSE:NVO)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
7 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$140.20 (73.2% Upside)

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/8/2025UBS GroupUpgradeSell ➝ Buy
1/6/2025Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
12/23/2024BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$156.00 ➝ $105.00
12/2/2024BNP ParibasUpgradeStrong-Buy
11/6/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
10/17/2024BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$160.00 ➝ $156.00
10/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
9/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00

#8 - Telefônica Brasil (NYSE:VIV)

Consensus Rating
Hold
Rating Score
2.4
Ratings Breakdown
2 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$10.47 (26.7% Upside)

About Telefônica Brasil

Telefônica Brasil logoTelefônica Brasil SA, together with its subsidiaries, operates as a mobile telecommunications company in Brazil. Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G, as well as mobile value-added and wireless roaming services. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/19/2024The Goldman Sachs GroupLower Price TargetBuy ➝ Buy$10.60 ➝ $9.20
12/9/2024New Street ResearchDowngradeBuy ➝ Neutral
11/25/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$11.50 ➝ $11.80
9/20/2024ScotiabankBoost Price TargetSector Perform ➝ Sector Perform$9.20 ➝ $10.40
8/1/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$11.00 ➝ $11.50
7/11/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight
5/9/2024BarclaysLower Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $12.00
4/23/2024BarclaysLower Price TargetEqual Weight ➝ Equal Weight$13.50 ➝ $13.00
2/26/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $13.50
1/5/2024Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$11.00

#9 - LATAM Airlines Group (NYSE:LTM)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$38.00 (37.6% Upside)

About LATAM Airlines Group

LATAM Airlines Group logoLATAM Airlines Group SA, together with its subsidiaries, provides passenger and cargo air transportation services in Peru, Argentina, the United States, Europe, Colombia, Brazil, Ecuador, Chile, the Asia Pacific, and rest of Latin America. The company operates in two segments, Air Transportation; and Multiplus Coalition and Loyalty Program. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/23/2024BarclaysBoost Price TargetOverweight ➝ Overweight$34.00 ➝ $38.00
10/8/2024The Goldman Sachs GroupUpgradeStrong-Buy
10/1/2024Morgan StanleyInitiated CoverageOverweight$40.00
8/21/2024Deutsche Bank AktiengesellschaftInitiated CoverageBuy$36.00
8/20/2024BarclaysInitiated CoverageOverweight$34.00

#10 - Clean Harbors (NYSE:CLH)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
8 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$269.44 (9.4% Upside)

About Clean Harbors

Clean Harbors logoClean Harbors, Inc provides environmental and industrial services in the United States and internationally. The company operates through two segments, Environmental Services and Safety-Kleen Sustainability Solutions. The Environmental Services segment collects, transports, treats, and disposes hazardous and non-hazardous waste, such as resource recovery, physical treatment, fuel blending, incineration, landfill disposal, wastewater treatment, lab chemicals disposal, and explosives management services; and offers CleanPack services, including collection, identification, categorization, specialized packaging, transportation, and disposal of laboratory chemicals and household hazardous waste. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/16/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$268.00 ➝ $268.00
1/13/2025OppenheimerBoost Price TargetOutperform ➝ Outperform$255.00 ➝ $256.00
12/11/2024Stifel NicolausBoost Price TargetBuy ➝ Buy$270.00 ➝ $290.00
12/6/2024TD CowenInitiated CoverageBuy$325.00
10/31/2024Truist FinancialBoost Price TargetBuy ➝ Buy$260.00 ➝ $280.00
10/31/2024Needham & Company LLCLower Price TargetBuy ➝ Buy$274.00 ➝ $268.00
10/31/2024Robert W. BairdLower Price TargetOutperform ➝ Outperform$300.00 ➝ $285.00
10/21/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$252.00 ➝ $270.00
8/1/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$235.00 ➝ $274.00
8/1/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$223.00 ➝ $256.00

#11 - Nokia Oyj (NYSE:NOK)

Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$5.86 (27.0% Upside)

About Nokia Oyj

Nokia Oyj logoNokia Oyj provides mobile, fixed, and cloud network solutions worldwide. The company operates through four segments: Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. The company provides fixed networking solutions, such as fiber and copper-based access infrastructure, in-home Wi-Fi solutions, and cloud and virtualization services; IP networking solutions, including IP access, aggregation, and edge and core routing for residential, mobile, enterprise and cloud applications; optical networks solutions that provides optical transport networks for metro, regional, and long-haul applications, and subsea applications; and submarine networks for undersea cable transmission. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/16/2025The Goldman Sachs GroupDowngradeNeutral ➝ Sell$3.60
1/6/2025Craig HallumBoost Price TargetBuy ➝ Buy$6.00 ➝ $7.00
12/9/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$4.35 ➝ $6.35
10/21/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$4.36 ➝ $4.35
10/18/2024DanskeUpgradeHold ➝ Buy
10/18/2024Northland SecuritiesReiterated RatingOutperform ➝ Outperform$6.50 ➝ $6.50
10/17/2024Craig HallumUpgradeHold ➝ Strong-Buy
9/4/2024Northland SecuritiesReiterated RatingOutperform ➝ Outperform$6.00 ➝ $6.50
4/16/2024JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$4.39 ➝ $4.26
1/19/2024BarclaysDowngradeEqual Weight ➝ Underweight

#12 - Mplx (NYSE:MPLX)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
8 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$49.89 (5.1% Downside)

About Mplx

Mplx logoMPLX LP engages in the operation of midstream energy infrastructure and logistics assets, and distribution fuels services. It operates through the Logistics and Storage (L&S) and Gathering and Processing (G&P) segments. The Logistics and Storage segment transports, stores, distributes, and markets crude oil, asphalt, refined petroleum products, and water. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2025BarclaysBoost Price TargetOverweight ➝ Overweight$49.00 ➝ $52.00
12/18/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$53.00 ➝ $54.00
11/19/2024Truist FinancialBoost Price TargetBuy ➝ Buy$48.00 ➝ $55.00
11/18/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $52.00
11/15/2024UBS GroupBoost Price TargetBuy ➝ Buy$51.00 ➝ $55.00
11/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $53.00
10/17/2024Bank of AmericaInitiated CoverageUnderperform$43.00
10/16/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$47.00 ➝ $50.00
10/10/2024BarclaysBoost Price TargetOverweight ➝ Overweight$45.00 ➝ $49.00
9/18/2024UBS GroupBoost Price TargetBuy ➝ Buy$49.00 ➝ $51.00

#13 - SS&C Technologies (NASDAQ:SSNC)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
6 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$77.75 (3.3% Downside)

About SS&C Technologies

SS&C Technologies logoSS&C Technologies Holdings, Inc, together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions comprising portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions consisting of claims adjudication, benefit management, care management, and business intelligence solutions. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/25/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$79.00 ➝ $85.00
10/25/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$90.00 ➝ $90.00
10/10/2024DA DavidsonReiterated RatingBuy ➝ Buy$92.00 ➝ $92.00
9/20/2024DA DavidsonBoost Price TargetBuy ➝ Buy$88.00 ➝ $92.00
9/19/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$75.00 ➝ $86.00
9/19/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$81.00 ➝ $90.00
7/29/2024DA DavidsonBoost Price TargetBuy ➝ Buy$84.00 ➝ $88.00
7/26/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$72.00 ➝ $75.00
7/26/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$74.00 ➝ $81.00
7/18/2024DA DavidsonBoost Price TargetBuy ➝ Buy$78.00 ➝ $84.00

#14 - Teva Pharmaceutical Industries (NYSE:TEVA)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
6 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$22.13 (1.2% Upside)

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/17/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$23.00 ➝ $30.00
12/18/2024BarclaysBoost Price TargetOverweight ➝ Overweight$25.00 ➝ $28.00
10/23/2024BarclaysBoost Price TargetOverweight ➝ Overweight$22.00 ➝ $25.00
10/21/2024JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$16.00 ➝ $18.00
9/3/2024UBS GroupBoost Price TargetBuy ➝ Buy$24.00 ➝ $26.00
8/1/2024BarclaysBoost Price TargetOverweight ➝ Overweight$21.00 ➝ $22.00
7/10/2024UBS GroupBoost Price TargetBuy ➝ Buy$22.00 ➝ $24.00
7/10/2024ArgusUpgradeHold ➝ Buy$20.00
6/27/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $23.00
6/5/2024BarclaysBoost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00

#15 - Coca-Cola FEMSA (NYSE:KOF)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$104.75 (38.7% Upside)

About Coca-Cola FEMSA

Coca-Cola FEMSA logoCoca-Cola FEMSA, SAB. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. The company offers sparkling beverages, including colas and flavored sparkling beverages; waters; other non-carbonated beverages comprising juice drinks, coffee, teas, milk, value-added dairy products, sports and energy drinks, and plant-based drinks; and alcoholic beverages, such as hard seltzer under the Topo Chico brand name. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/30/2024BarclaysLower Price TargetOverweight ➝ Overweight$110.00 ➝ $108.00
10/29/2024CitigroupUpgradeNeutral ➝ Buy$93.00 ➝ $102.00
9/3/2024The Goldman Sachs GroupUpgradeNeutral ➝ Buy
7/31/2024BarclaysBoost Price TargetOverweight ➝ Overweight$105.00 ➝ $110.00
7/15/2024BarclaysLower Price TargetOverweight ➝ Overweight$115.00 ➝ $105.00
7/10/2024UBS GroupLower Price TargetBuy ➝ Buy$112.00 ➝ $102.00
4/16/2024UBS GroupBoost Price TargetBuy ➝ Buy$109.00 ➝ $112.00
4/12/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$102.00 ➝ $107.00
4/12/2024ScotiabankUpgradeSector Perform ➝ Sector Outperform
2/2/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$89.00 ➝ $102.00

#16 - Rithm Capital (NYSE:RITM)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
7 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.94 (13.8% Upside)

About Rithm Capital

Rithm Capital logoRithm Capital Corp. operates as an asset manager focused on real estate, credit, and financial services. It operates through Origination and Servicing, Investment Portfolio, Mortgage Loans Receivable, and Asset Management segments. Its investment portfolio primarily comprises of mortgage servicing rights (MSR), and MSR financing receivables, title, appraisal and property preservation, excess MSRs, and services advance investments; real estate securities, call rights, SFR properties, and residential mortgage loans; consumer and business purpose loans; and asset management related investments. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/7/2025B. RileyUpgradeStrong-Buy
12/3/2024Keefe, Bruyette & WoodsBoost Price TargetOutperform ➝ Outperform$13.00 ➝ $13.50
11/21/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$13.00 ➝ $13.00
11/7/2024WedbushReiterated RatingOutperform$14.00
8/16/2024WedbushReiterated RatingOutperform ➝ Outperform$13.00 ➝ $13.00
8/13/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$13.00 ➝ $13.00
7/19/2024JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $12.50
5/14/2024Piper SandlerBoost Price TargetNeutral ➝ Neutral$10.50 ➝ $12.50
5/10/2024B. RileyReiterated RatingBuy ➝ Buy$13.00 ➝ $14.00
5/9/2024WedbushReiterated RatingOutperform ➝ Outperform$13.00

#17 - Rambus (NASDAQ:RMBS)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$74.67 (18.4% Upside)

About Rambus

Rambus logoRambus Inc provides semiconductor products in the United States, South Korea, Singapore, and internationally. The company offers DDR memory interface chips, including DDR5 and DDR4 memory interface chips to module manufacturers, OEMs, and hyperscalers; silicon IP, such as interface and security IP solutions that move and protect data in advanced data center, government, and automotive applications; and interface IP solutions for high-speed memory and chip-to-chip digital controller IP. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/25/2024Baird R WUpgradeStrong-Buy
11/25/2024Robert W. BairdInitiated CoverageOutperform$90.00
11/11/2024Loop CapitalInitiated CoverageBuy$70.00
11/6/2024Wells Fargo & CompanyInitiated CoverageOverweight$62.00
10/29/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$85.00 ➝ $85.00
9/10/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$85.00 ➝ $85.00
7/26/2024SusquehannaLower Price TargetPositive ➝ Positive$75.00 ➝ $66.00
5/13/2024Jefferies Financial GroupReiterated RatingBuy ➝ Buy$72.00 ➝ $75.00
3/13/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$85.00
2/6/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$85.00

#18 - United Airlines (NASDAQ:UAL)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
18 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$106.45 (3.7% Downside)

About United Airlines

United Airlines logoUnited Airlines Holdings, Inc, through its subsidiaries, provides air transportation services in North America, Asia, Europe, Africa, the Pacific, the Middle East, and Latin America. The company transports people and cargo through its mainline and regional fleets. It also offers catering, ground handling, flight academy, and maintenance services for third parties. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/9/2025JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$108.00 ➝ $133.00
1/7/2025SusquehannaBoost Price TargetPositive ➝ Positive$85.00 ➝ $120.00
1/7/2025UBS GroupBoost Price TargetBuy ➝ Buy$139.00 ➝ $140.00
12/30/2024Raymond JamesBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $120.00
12/11/2024Morgan StanleyBoost Price TargetOverweight ➝ Overweight$88.00 ➝ $130.00
12/2/2024Melius ResearchUpgradeStrong-Buy
11/26/2024Dbs BankUpgradeHold ➝ Strong-Buy
11/26/2024CitigroupBoost Price TargetBuy ➝ Buy$98.00 ➝ $122.00
11/26/2024UBS GroupReiterated RatingBuy$139.00
11/19/2024TD CowenBoost Price TargetBuy ➝ Buy$100.00 ➝ $125.00

#19 - Sysco (NYSE:SYY)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
11 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$85.79 (16.8% Upside)

About Sysco

Sysco logoSysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. It operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
1/21/2025Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$82.00 ➝ $79.00
12/18/2024Melius ResearchUpgradeHold
12/18/2024MeliusInitiated CoverageHold$85.00
12/16/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$91.00 ➝ $95.00
10/30/2024Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$87.00 ➝ $82.00
9/25/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$91.00 ➝ $92.00
9/16/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$85.00 ➝ $88.00
7/31/2024BarclaysBoost Price TargetOverweight ➝ Overweight$85.00 ➝ $88.00
7/18/2024Bank of AmericaLower Price TargetBuy ➝ Buy$91.00 ➝ $87.00
7/16/2024Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$82.00 ➝ $81.00

#20 - Corcept Therapeutics (NASDAQ:CORT)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$65.25 (6.8% Upside)

About Corcept Therapeutics

Corcept Therapeutics logoCorcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/31/2024HC WainwrightReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
10/18/2024Sandler O'NeillReiterated RatingBuy ➝ Buy
10/18/2024HC WainwrightBoost Price TargetBuy ➝ Buy$45.00 ➝ $80.00
9/30/2024Truist FinancialBoost Price TargetBuy ➝ Buy$65.00 ➝ $76.00
9/18/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $67.00
7/30/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
7/30/2024HC WainwrightBoost Price TargetBuy ➝ Buy$40.00 ➝ $45.00
7/30/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$35.00 ➝ $38.00
7/1/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$35.00 ➝ $35.00
6/17/2024Truist FinancialReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00

More Investing Slideshows: